Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08UVZ
|
|||
| Former ID |
DNCL002050
|
|||
| Drug Name |
E004
|
|||
| Indication | Asthma [ICD-11: CA23; ICD-10: J45, J45.8; ICD-9: 493] | Phase 3 | [1] | |
| Company |
Amphastar Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
CH2BrNO2
|
|||
| Canonical SMILES |
C([N+](=O)[O-])Br
|
|||
| InChI |
1S/CH2BrNO2/c2-1-3(4)5/h1H2
|
|||
| InChIKey |
DNPRVXJGNANVCZ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 563-70-2
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01357642) Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.